<DOC>
	<DOCNO>NCT00992667</DOCNO>
	<brief_summary>The aim study investigate effect inhale apocynin ROS ( reactive oxygen specie ) NOS ( reactive nitrogen specie ) synthesis 10 nonsmoking mild asthmatic . Effects nebulized apocynin ( 0.5 mg/ml , 6 ml ) assess exhaled breath condensate ( EBC ) 30 , 60 120 minute .</brief_summary>
	<brief_title>Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations Exhaled Breath Condensate Mild Asthmatics</brief_title>
	<detailed_description>The study double-blind , placebo-controlled , cross-over design , consist 2 visit , separate 30 ± 10 day . If first visit drug use , second visit - placebo vice versa . Before procedure , safety measure ( arterial blood pressure , heart rate value , cough scale ) perform . The effect possible inhibitor ROS formation perform use corticosteroid-naive asthmatic subject , prone oxidative stress healthy non-smoking subject . The study protocol approve Ethics Committee Medical University Lodz ( . RNN/12/08/KE ) write consent obtain every subject prior study . EBC collect use modification method describe previously Doniec et al.2005 . The subject breathe spontaneously mouthpiece 20 min . Each subject wear nose clip procedure . Approximately 2 ml condensate collect immediately store −80°C procedure H2O2 , NO2- NO3- measurement . 6 ml apocynin total dose 3 mg ( 0.5 mg/ml ) nebulized mouthpiece use nose clip . The H2O2 concentration EBC measure accord method apply previously Nowak et al.2001 . Determination NO2- NO3- Griess solution perform micromethod , carry 96-well plate , accord Griess ' method , modify method describe Dziedzic et al.2003 .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Acetovanillone</mesh_term>
	<criteria>patient suffer bronchial asthma ( mild ) patient free medication least 7 day research patient suffer infectious disease include upper respiratory tract infection least 3 month prior study patient suffer moderate severe asthma patient take medication 7 less day study infectious disease occur 3 month less study</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>56 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>apocynin</keyword>
	<keyword>asthma</keyword>
</DOC>